Cardiovascular disease remains the number one killer of all Americans and is a leading cause of death worldwide. Pharmacotherapy in cardiovascular disease is a rapidly changing and dynamic field due to the high degree of investigational efforts applied to this area. Core areas in which there have been a number of significant changes in practice over the last 10-20 years include the treatment of acute coronary syndromes, heart failure, secondary prevention of cardiovascular disease, and atrial fibrillation.
• Identify advances made in the pharmacotherapeutic treatment of cardiovascular disease
• Discuss the pharmacology of agents commonly used to treat cardiovascular disease
• Develop a rational pharmaceutical care plan for a patient with an acute coronary syndrome, atrial fibrillation, or chronic heart failure
• Identify appropriate monitoring and safety concerns for medications commonly used in cardiovascular disease
• Discuss the results from recently published clinical trials in the primary literature and their potential impact on clinical practice guidelines developed for the treatment of cardiovascular diseases.
• Identify areas of future research in key cardiovascular areas
All faculty members participating in continuing education programs sponsored by the University of Kentucky College of Medicine are expected to disclose any real or apparent conflict of interest related to the content of their presentations. In addition, if a product is not labeled for the use discussed, or is still investigational, it will be made known. Disclosures are located in your program material.
